1-ethyl-3-azabicyclo[3.1.0]hexane hydrochloride, 95.0%, 250mg

Trans-4-ethoxyphenyl 4-butylcyclohexanecarboxylate, 97.0%, 250mg

1-(3-Fluoro-5-methoxyphenyl)ethanone, 97.0%, 1g

2'-Fluoro-biphenyl-2-carboxylic acid, 95.0%, 5g

9-Acridinecarboxylic acid, monohydrate, 97%, 100g

2-(2-(Difluoromethyl)-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

2-Bromo-1H-imidazole, 98.0%, 25g

4-Chloro-5-(trifluoromethyl)quinazoline, 97%, 250mg

1-(Ethoxycarbonyl)piperidine-4-carboxylic acid, 95.0%, 25g

Vinyl tris-tert-Butoxysilane, 10g

N-(4-Chloro-3-fluorophenyl)-2,2,2-trifluoroacetamide, 97%, 250mg

5,6,11,12-Tetraphenylnaphthacene (purified by sublimation)>99.0%(GC)1g

GC capillary column ROTI®Cap-5 HT, 15 m, 0.32 mm, 0.25 µm, 1 Piece(s)